0
Posted in Research Papers
February 6, 2015

2015

2015

Novitsky V, Kühnert D, Moyo S, Widenfelt E, Okui L, Essex M. Phylodynamic analysis of HIV sub-epidemics in Mochudi, BotswanaEpidemics. 2015 Dec


Wirth KE, Agniel D, Barr CD, Austin MD, DeGruttola V. A composite likelihood approach for estimating HIV prevalence in the presence of spatial variation. Stat Med. 2015 Dec 10


Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R. Trends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013AIDS. 2015 Dec 3


Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, Lebelonyane R, Pilatwe PT, Hamunime N, Okello V, Mutasa-Apollo T, Mugurungi O, Murungu J, Dzangare J, Kwesigabo G, Wabwire-Mangen F, Mulenga M, Hachizovu S, Ettiegne-Traore V, Mohamed F; MSAE, Bashorun A, Nhan do T, Hai NH, Quang TH, Van Onacker JD, Francois K, Robin EG, Desforges G, Farahani M, Kamiru H, Nuwagaba-Biribonwoha H, Ehrenkranz P, Denison JA, Koole O, Tsui S, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro TD, Hamilton CD, Abiri OO, Griswold M, Pierre E, Xavier C, Alfredo C, Jobarteh K, Letebele M, Agolory S, Baughman AL, Mutandi G, Preko P, Ryan C, Ao T, Gonese E, Herman-Roloff A, Ekra KA, Kouakou JS, Odafe S, Onotu D, Dalhatu I, Debem HH, Nguyen DB, Yen le N, Abdul-Quader AS, Pelletier V, Williams SG, Behel S, Bicego G, Swaminathan M, Dokubo EK, Adjorlolo-Johnson G, Marlink R, Lowrance D, Spira T, Colebunders R, Bangsberg D, Zee A, Kaplan J, Ellerbrock TV. Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women – 12 Countries, 2002-2013MMWR Morb Mortal Wkly Rep. 2015 Nov 27


Moyo S, Wilkinson E, Novitsky V, Vandormael A, Gaseitsiwe S, Essex M, Engelbrecht S, de Oliveira T. Identifying Recent HIV Infections: From Serological Assays to Genomics. Viruses. 2015 Oct 23


Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R. Variation in attrition at sub-national level: Review of the Botswana National HIV/AIDS Treatment (Masa) program data (2002-2013). Trop Med Int Health. 2015 Oct 20


Zash R, Souda S, Chen JY, Binda K, Dryden-Peterson S, Lockman S, Mmalane M, Makhema J, Essex M, Shapiro R. Reassuring Birth Outcomes with Tenofovir/Emtricitabine/Efavirenz used for Prevention of Mother to Child Transmission of HIV in BotswanaJ Acquir Immune Defic Syndr. 2015 Sep 12


Schaan MM, Taylor M, Gungqisa N, Marlink R. Personal views about womanhood amongst women living with HIV in BotswanaCult Health Sex. 2015 Aug 25


Novitsky V, Zahralban-Steele M, McLane MF, Moyo S, van Widenfelt E, Gaseitsiwe S, Makhema J, Essex M. Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV ClusteringJ Clin Microbiol. 2015 Aug


Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana. BMC Infect Dis. 2015 Aug 13


Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR 3rd, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Cancer Incidence following Expansion of HIV Treatment in BotswanaPLoS One. 2015 Aug 12


De Neve JW, Fink G, Subramanian SV, Moyo S, Bor J. Length of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment. Lancet Glob Health. 2015 Aug 3


Novitsky V, Bussmann H, Okui L, Logan A, Moyo S, van Widenfelt E, Mmalane M, Lei Q, Holme MP, Makhema J, Lockman S, Degruttola V, Essex M. Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana communityJ Int AIDS Soc. 2015 May 29


Novitsky V, Moyo S, Lei Q, DeGruttola V, Essex M. Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV Clustering AIDS Res Hum Retroviruses. 2015 May


Moyo S, Cox HS, Hughes J, Daniels J, Synman L, De Azevedo V, Shroufi A, Cox V, van Cutsem G. Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa. PLoS One. 2015 Mar 18


Dryden-Peterson S, Bennett K, Hughes MD, Veres A, John O, Pradhananga R, Boyer M, Brown C, Sakyi B, van Widenfelt E, Keapoletswe K, Mine M, Moyo S, Asmelash A, Siedner M, Mmalane M, Shapiro RL, Lockman S. An Augmented SMS Intervention to Improve Access to Antenatal CD4 Testing and ART Initiation in HIV-Infected Pregnant Women: A Cluster Randomized TrialPLoS One. 2015 Feb 18


Novitsky V, Moyo S, Lei Q, DeGruttola V, Essex M. Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV ClusteringAIDS Res Hum Retroviruses. 2015 Jan 6

Comments & Reviews

Your email address will not be published. Required fields are marked *

*